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Summary
Background: In preimplantation mouse embryos, the first cell
fate specification to the trophectoderm or inner cell mass
occurs by the early blastocyst stage. The cell fate is controlled
by cell position-dependent Hippo signaling, although the
mechanisms underlying position-dependent Hippo signaling
are unknown.
Results: We show that a combination of cell polarity and
cell-cell adhesion establishes position-dependent Hippo
signaling, where the outer and inner cells are polar and
nonpolar, respectively. The junction-associated proteins
angiomotin (Amot) and angiomotin-like 2 (Amotl2) are essen-
tial for Hippo pathway activation and appropriate cell fate
specification. In the nonpolar inner cells, Amot localizes to
adherens junctions (AJs), and cell-cell adhesion activates the
Hippo pathway. In the outer cells, the cell polarity sequesters
Amot from basolateral AJs to apical domains, thereby sup-
pressing Hippo signaling. The N-terminal domain of Amot is
required for actin binding, Nf2/Merlin-mediated association
with the E-cadherin complex, and interaction with Lats protein
kinase. In AJs, S176 in the N-terminal domain of Amot is phos-
phorylated by Lats, which inhibits the actin-binding activity,9Present address: Department of Molecular Medical Science, Faculty of
Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510,
Japan
10Present address: TransGenic, Kobe, Hyogo 650-0047, Japan
*Correspondence: sasaki@kumamoto-u.ac.jpthereby stabilizing the Amot-Lats interaction to activate the
Hippo pathway.
Conclusions:We propose that the phosphorylation of S176 in
Amot is a critical step for activation of the Hippo pathway in
AJs and that cell polarity disconnects the Hippo pathway
from cell-cell adhesion by sequestering Amot from AJs. This
mechanism converts positional information into differential
Hippo signaling, thereby leading to differential cell fates.
Introduction
During preimplantation development, mouse embryos form
blastocysts that comprise two cell types: the outer epithelial
trophectoderm (TE) layer and the inner cell mass (ICM). TE is
required for implantation and later contributes to the placenta.
ICM further differentiates into the pluripotent epiblast, which
later forms the embryo proper and the primitive endoderm.
Historically, twomodels have been proposed for the first cell
fate specification process: the inside-outside (or positional)
model [1], in which the cell positionwithin the embryo specifies
the cell fate, and the polarity model [2], in which the acquisition
of cell polarity at the eight-cell stage is a critical step in the
establishment of differential cell fates. The polarity model
was further developed to include the promotion of TE fate
based on the presence of the apical domain [3, 4]. We recently
found that Hippo signaling pathway components, i.e., the
TEAD family transcription factor Tead4 [5–7], its coactivator
proteins Yap (encoded by Yap1) and Taz (encoded by
Wwtr1), and the protein kinases Lats1/2, play critical roles in
this cell fate specification process [6, 8]. In the inner cells,
cell-cell adhesions activate Hippo signaling, which inactivates
Tead4 by suppressing the nuclear accumulation of Yap. In the
outer cells, weak Hippo signaling facilitates the nuclear accu-
mulation of Yap. The resulting active Tead4-Yap complex
induces the TE-specific transcription factors Cdx2 and
Gata3, which promote differentiation into TE [6, 9]. Therefore,
establishment of position-dependent Hippo signaling is a
critical step during differential cell fate specification, which
supports the inside-outside model [6, 8]. We previously pro-
posed that a possible mechanism for differential Hippo
signaling may be differences in the degrees of cell-cell con-
tacts between the inner and outer cells [6]. However, the exact
mechanisms underlying position-dependent Hippo signaling
remain largely unknown.
In support of the polarity model, several recent studies
have suggested the importance of cell polarity during TE
development. The Par-aPKC system plays central roles in
the regulation of the apicobasal polarity of cells (see reviews
in [10–12]). Knockdown of Pard6b resulted in the reduced
expression of Cdx2 and the failure of functional TE formation
[13]. The complete absence of E-cadherin disrupted cell polar-
ization, while the membrane localization of PKCz correlated
with the nuclear accumulation of Yap and the expression of
Cdx2 [14]. These observations suggest that cell polarity is
probably important for cell fate specification and the regula-
tion of Hippo signaling in preimplantation embryos. Studies
in Drosophila also suggest that the cell polarity regulators
Crumbs and aPKC control Hippo signaling in epithelial cells
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Figure 1. Combination of Cell Polarity and Cell-Cell Adhesion Establishes Position-Dependent Hippo Signaling in 32-Cell Stage Preimplantation Embryos
(A) Effects of Pard6b knockdown (KD) on the apical domain marker PKCl/z and Yap. Nuclear Yap was reduced in the outer cells of Pard6b KD
embryos.
(B) Quantification of the ratio of nuclear (N) to cytoplasmic (C) Yap shown in (A). ns, not significant. ***p < 0.001.
(C) Increase in p-Yap in the outer cells of Pard6b KD embryos.
(D) Quantification of the signal intensity of p-Yap shown in (C). ns, not significant. ***p < 0.001.
(E) PKCl2/2:PKCz2/2 embryos with reduced nuclear Yap in the outer cells.
(legend continued on next page)
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1183[15–18], although the relationships between cell polarity and
the Hippo activation status are opposite in fly epithelial cells
and preimplantation embryos. Thus, the exact roles andmech-
anisms of cell polarity during the regulation of Hippo signaling
in preimplantation embryos remain unknown.
The Hippo pathway is controlled by various stimuli (see
reviews and references in [19–21]). Cell-cell adhesion is an
important activation signal for the Hippo pathway, although
the mechanisms that connect junctions to Hippo signaling
remain largely unknown. Angiomotin (Amot)-family proteins
(Amot, angiomotin-like 1 [Amotl1]/JEAP, and angiomotin-like
2 [Amotl2]/MASCOT [22]) are Hippo signaling components
[23, 24] that bind to the tight junction proteins MUPP1/Patj
[25, 26]. Amot proteins also bind to Yap/Taz and the Nf2 tumor
suppressor protein Merlin [23, 24, 27, 28]. Therefore, Amot is a
potentially important protein that may connect junctions and
the Hippo pathway.
In this study, we analyzed the roles of cell polarity during
regulation of Hippo signaling in preimplantation embryos.
We found that a combination of cell polarity and cell-cell adhe-
sion established position-dependent Hippo signaling. We also
found that phosphorylation of Amot at adherens junctions
(AJs) stabilized its interaction with Lats and activated the
Hippo pathway. Thus, cell polarity control through the junc-
tional localization of Amot is the molecular basis for establish-
ment of cell position-dependent Hippo signaling and the
regulation of cell fate.
Results
Combination of Cell Polarity and Cell Adhesion
Establishes Position-Dependent Hippo Signaling in
Preimplantation Embryos
To examine the role of cell polarity during the regulation of Yap,
we initially focused on the apical domain regulator aPKC-Par6-
Par3 complex, which we disrupted by knocking down Pard6b
via pronuclear injection of short hairpin RNA (shRNA) expres-
sion plasmids. As demonstrated previously [13], shPard6b
clearly reduced Pard6b proteins around the 32-cell stage,
which disrupted the apical domain, as indicated by reduction
in apically localized PKCl/z (n = 5/5) and p-ERM (n = 6/6) (Fig-
ure 1A; see also Figure S1A available online). In contrast, the
distributions of the basolateral regulators Scribble (n = 8/8)
and Lgl1 (n = 3/3) were expanded into the outside domains
(Figure S1A, dots).
In these apical domain-disrupted embryos, nuclear Yap sig-
nals were markedly reduced in the outer cells (n = 9/9, Figures
1A and 1B). In this paper, Yap is used to describe Yap and Taz
because the anti-Yap antibody detects both proteins. The acti-
vation of Hippo signaling promotes the phosphorylation of Yap
(p-Yap), including the 112th serine residue (S112) by Lats1/2
[29]. In normal embryos, the p-Yap signal or Hippo signaling
is strong in the inner cells and weak in the outer cells (Figures
1C and 1D) [6]. In Pard6b knockdown (KD) embryos, the levels
of p-Yap signals in the outer cells were increased to a level(F and G) Expression of Cdx2 in 32-cell stage Pard6b KD embryos. Represent
classified into three categories, depending on the Cdx2 expression level (G).
The numbers in the graphs indicate the numbers of embryos in each category
(H–L) Effects of cell dissociation on the Yap distribution in normal and Pard6b
(H) Schematic representation of the cell dissociation experiments.
(I and J) Distribution of Yap in dissociated control (uninjected) embryos.
(K and L) Distribution of Yap in dissociated Pard6b KD embryos.
Quantification of Yap distribution in (J) and (L). ***p < 0.001. See Figure S1 forsimilar to that in the inner cells (Figures 1C and 1D, n = 9/9).
Consistent with the importance of Hippo signaling for cell
fate control, Pard6b KD embryos had lower Cdx2 expression
at the 32-cell stage (Figures 1F and 1G).
Essentially, the same results were obtained after suppress-
ing PKCl/z activity through overexpression of dnPKCl (the
kinase activity-negative form of PKCl) [30] (Figure S1B) (Yap:
n = 15/16; p-Yap: n = 8/9) and the genetic ablation of aPKC
in PKCl2/2:PKCz2/2 embryos (Figure 1E, n = 3/3; Figures
S1F and S1G) [31]. Overall, these results suggest that the
presence of an apical domain suppresses Hippo signaling in
the outer cells.
Disruption of the apical Par-aPKC complex activated the
Hippo pathway. To understand whether this activation re-
quires cell-cell adhesions, we dissociated 32-cell stage
embryos and examined the distribution of Yap. To mark the
original cell position within the embryos, we labeled the outer
cells with the red fluorescent dye PKH26 before dissociation
[32] (Figure 1H). The inner and outer cells of the normal undis-
sociated embryos exhibited clear cytoplasmic and nuclear
Yap, respectively (Figures 1A and 1J). When these embryos
were dissociated, all the cells exhibited clear nuclear Yap, irre-
spective of the original cell position (Figures 1I and 1J). In the
undissociated Pard6b KD embryos, 84% of the outer cells had
cytoplasmic Yap (Figures 1A and 1L). After the Pard6b KD
embryos were dissociated, the majority of the outer and inner
cells exhibited nuclear Yap or nuclear and cytoplasmic Yap
(Figures 1K and 1L). These results suggest that cell adhesion
is required for all blastomeres to exclude Yap from the nuclei.
Therefore, in the outer cells of normal embryos, the presence
of the apical domain or the operation of the Par-aPKC system
inhibits the activation of the Hippo pathway via cell-cell
adhesion.
The Hippo Pathway Component Amot Has a Cell
Position-Dependent Differential Distribution
Amot is a junction-associated Hippo pathway component
[23, 24]. There are two isoforms of Amot protein: p130 Amot
(Amot130) and p80 Amot (Amot80), the latter lacking the
N-terminal portion of Amot130 [33] (Figure 4A). We focused
on Amot130, which we refer to as Amot unless stated other-
wise. Yeast two-hybrid screening of Amot-interacting proteins
identified Yap. Like other researchers, we found that multiple
Hippo pathway components, including Merlin, Lats2, and
Kibra, also bind to Amot [23, 24, 27, 28] (Figures 4D, 4E, and
S4A–S4C).
In the 32-cell stage, Amot proteins had different subcellular
distributions in the inner and outer cells (Figure 2A). In the outer
cells, Amot was localized to the apical membrane and was not
present in the basolateral membrane. In the inner cells, Amot
was distributed throughout the plasma membrane and weakly
in the cytoplasm. The polarized Amot distribution in the outer
cells was established via cell polarization during compaction
of the eight-cell stage embryos (Figures 2A and S2A). The
cell position-dependent differential distribution of Amot wasative Pard6b KD embryo with reduced Cdx2 expression (F). Embryos were
A representative embryo for each category is shown in the upper panels.
.
KD embryos.
related data.
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Figure 2. The Junction-Associated Hippo Component Angiomotin Has Different Position- and Polarity-Dependent Distributions in Preimplantation
Embryos
(A) Correlation between the position-dependent distributions of Amot and Yap in eight-cell stage embryos and blastocysts. 8c-cell, compacted eight-cell
stage.
(B) Amot distribution in the outer cells relative to the distributions of ZO-1 and E-cadherin. Note that the ZO-1 signals in the inner cells were significantly
weaker than those in the outer cells (tight junctions). Therefore, the ZO-1 signals in the inner cells are not visible in this panel.
(C) Comparison of the Amot distribution in the inner cells with those of ZO-1 and E-cadherin.
(D) Schematic representation showing the distributions of Amot and Yap proteins in the inner and outer cells of normal and polarity-disrupted embryos.
(E) Amot distribution in PKCl/z-inhibited embryos.
(F) Amot distribution in Pard6b KD embryos.
(G)Par1a/bDKDdisrupted the Amot distribution andHippo signaling. The arrowhead indicates an inner cell with nuclear exclusion of Yap in the absence of a
clear Amot signal in the cytoplasm. Therefore, cytoplasmic Amot is probably not important for the regulation of Yap.
See Figure S2 for related data.
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stage, and this difference was maintained until the early blas-
tocyst stage (Figure 2A). The absence of Amot protein from the
basal membrane of polarized cells was detected in the outer
cells of the blastocysts (Figure 2A).
Importantly, the presence of Amot proteins in the apical
membrane or throughout the plasma membrane was always
correlated with the presence of Yap in the nuclei or in thecytoplasm, respectively (Figures 2A and 2D). In the outer
cells, Amot was present at tight junctions, where it overlapped
with two major junction proteins, ZO-1 and E-cadherin (Fig-
ure 2B). In the inner cells, Amot colocalized with ZO-1 and
E-cadherin (Figure 2C), which suggested that Amot was
present in the vicinity of AJs. Of the junctional Hippo compo-
nents, these correlations were probably specific to Amot,
because three other Hippo components, i.e., Merlin, Kibra,
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1185and a-catenin, were present throughout the plasmamembrane
(Figures S2B–S2D).
The Par-aPKC System Controls the Distribution of Amot
Amot localized to the apical domains in polarized cells, and
thus, we examined the role of the apical regulator, Par-
aPKC, during the regulation of Amot. In embryos expressing
dnPKCl, the apical restriction of Amot was absent from the
outer cells. Amot was also present in the basolateral mem-
brane, similar to the inner cells (n = 4/4) (Figure 2E). Pard6b
KD embryos produced the same results (n = 17/18) (Figure 2F).
Thus, the subcellular distribution of Amot was controlled by
the apical Par-aPKC complex.
The activity of the apical Par-aPKC complex is suppressed
by the basolateral regulator Par1 [10], and thus, we examined
the effects of downregulating two Par1 proteins, Par1a and
Par1b, by coinjecting shRNA plasmids for Par1a/b (Fig-
ure S2E). Par1a/b double knockdown (DKD) embryos
exhibited no apparent changes in apically localized PKCl/z
(n = 6/7) and Pard6b (n = 6/6) or the basolateral localization
of E-cadherin (n = 6/6) (Figure S2F). However, the Amot distri-
bution was changed (n = 7/7), and Amot was present in the
lateral membrane of the outer cells, thereby mimicking the
inner cells (Figure 2G). The importance of the junctional local-
ization of Amot in the Hippo pathway activationwas supported
further because Yap was excluded from the nuclei of the outer
cells (n = 7/10) (Figures 2D and 2G), while the phosphorylation
of Yap was increased in the outer cells (n = 3/3) (Figure 2G).
These results suggest that the Par-aPKC system, including
Par1, controls the junctional localization of Amot and Hippo
signaling in the outer cells.
Amot-Family Proteins Are Required for Activation of the
Hippo Pathway
To examine the role of Amot, we used Amot mutant embryos
[34]. Amot null mutant embryos (Amot2/2 or Amot2/Y; Amot
is on the X chromosome) lacked Amot proteins (Figure S3A),
and these embryos failed to exclude Yap from the nuclei of
the inner cells until the 32-cell stage (Figures 3A, 3F, and 3F0;
the subcellular distribution of Yap in the inner cells was deter-
mined semiquantitatively based on the Yap localization index
[YLI]: 1 = cytoplasmic Yap, 5 = nuclear Yap). The strong
p-Yap signals in the inner cells were also reduced (n = 14/14)
(Figure 3A), which supports the importance of Amot in acti-
vating the Hippo pathway and regulating Yap. Pard6b KD in
Amot mutant embryos led to nuclear Yap in all cells (n = 3/4)
(Figure 3B), resembling the Amot mutants, which indicates
that Amot functions downstream of cell polarity.
In the later stages, however, the inner cells of most Amot
mutants exhibited moderate nuclear Yap (Figures 3A and
3F), and Amot mutants survived until the postimplantation
stages [34]. There are two other Amot-family genes, Amotl1
and Amotl2, and thus, we hypothesized that these proteins
may also play roles in the regulation of Yap. Indeed, Amotl2
(but not Amotl1) was expressed (Figure 3C; data not shown).
In wild-type embryos, Amotl2 was localized only to the apical
membrane of the outer cells (Figure 3C). However, in Amot
mutant embryos, it was interesting that Amotl2 also localized
to the plasma membrane of the inner cells, similar to Amot
(Figure 3C).
To examine the role of Amotl2, we knocked down Amotl2
by siRNA injection. In Amotl2 KD embryos, Amotl2 protein
was clearly reduced, but these embryos exhibited a normal
Yap distribution and Hippo pathway activation, which wasmonitored based on p-Yap (Figures S3B and S3C). However,
when Amotl2 KD was performed with Amot mutants, these
embryos, which we describe as Amot-free embryos, exhibited
strong nuclear localization of Yap in the inner cells, even in the
later stages (n = 30/30) (Figures 3D and 3F), and the activation
of the Hippo pathwaywas almost completely lost (n = 7/7) (Fig-
ure 3E). Therefore, Amot-family proteins are essential for the
activation of the Hippo pathway in preimplantation embryos,
where Amot and Amotl2 play major and supplementary roles,
respectively. Consistent with the idea that cell polarity acts
upstream of Amot, Amot-free embryos had a normal distribu-
tion of PKCl/z (n = 5/5) (Figure S3D).
At E4.5, the Amot-free embryos exhibited two morpholog-
ical types: a blastocyst-like morphology (type I) and a cyst
lacking inner cells (type II). In both types, all the cells strongly
expressed the TE regulator Cdx2 (n = 27/27) (Figures 3G, 3H,
and S3E). Two similar phenotypes were also observed with
Lats1/2 doublemutants, in which the Hippo pathwaywas inac-
tive (Figure S3F) [6]. In Amot-free embryos, the expression of
the epiblast marker Nanog was lost or significantly reduced
(n = 2/2) (Figure 3G), while expression of the primitive endo-
derm marker Gata6 was lost (n = 3/3) (Figure 3H). Formation
of blastocoels in Amot-free embryos suggested the formation
of functional TE because Tead42/2 and Pard6b KD embryos,
which lacked TE, failed to form blastocoels. Therefore, activa-
tion of the Hippo pathway by Amot-family proteins is critically
important for appropriate cell fate specification.
The N-Terminal and Coiled-Coil Domains Are Required for
Efficient Activation of the Hippo Pathway In Vivo
To understand themechanisms that allow Amot to activate the
Hippo pathway in AJs, we performed in vivo domain analysis
of Amot. We injected the RNAs of various Amot proteins
(Figure 4A), together with siAmotl2, into both blastomeres of
two-cell stage Amot mutant embryos and examined the
rescue activities of the expressed Amot proteins. Injection
with an appropriate dose of the Amot130 RNA clearly rescued
the mutant phenotype, which was demonstrated by the
nuclear exclusion of Yap in the inner cells (Figures 4B and
4C). The expressed Amot proteins had similar distribution
patterns to the endogenous proteins (Figure 4B). Overexpres-
sion of Amot led to the formation of abnormal F-actin-medi-
ated aggregates in the cytoplasm and the nuclear exclusion
of Yap in the outer cells (data not shown). Therefore, we
used the same RNA dose for all constructs to ensure that
they were expressed at physiological levels.
Expression of Amot80, which lacks the N-terminal domain,
failed to rescue the Amot-free phenotype (Figures 4A–4C).
The Amot80 protein level was low, and the localization of
Amot80 to inner cell AJs was not seen clearly (Figure 4B).
Expression of Amot-DCC, which lacks the central coiled-coil
domain, also failed to rescue Amot-free embryos (Figures
4A–4C). In this case, however, Amot-DCC proteins were abun-
dant, including AJs. These results suggest that the N-terminal
and coiled-coil domains are both required for activation of the
Hippo pathway, while the N-terminal domain is required for the
localization of Amot proteins to AJs and probably to maintain
their stability. It appears that Amot is stabilized in the AJs of
Hippo-active cells. The role of the coiled-coil domain in the
Hippo pathway activation is distinct from that in the N-terminal
domain.
The N-terminal domain contains three PY motifs. The first
two PY motifs interact with NEDD4-like E3 ubiquitin ligase
[35] and Yap [23, 24, 27], respectively. We found that the third
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Figure 3. Amot-Family Proteins Are Required for Hippo Pathway Activation in Preimplantation Embryos
(A) Distribution of Yap and p-Yap proteins in Amot mutant (Amot-KO) embryos. The numbers in the upper panels indicate the number of nuclei in the
embryos shown.
(B) Distribution of Yap in Pard6b KD Amot mutant embryos.
(C) Distribution of Amotl2 proteins in wild-type and Amot mutant embryos.
(D) Distribution of Yap in Amot mutant and Amot-free embryos. Amot-free indicates Amotl2 KD in Amot mutant embryos.
(E) Distribution of p-Yap in Amot mutant and Amot-free embryos. Note that virtually no p-Yap signal was observed in Amot-free embryos.
(F) Ontogenic change in the subcellular distribution of Yap in the inner cells. The subcellular distribution of Yap was determined semiquantitatively based on
the Yap localization index (YLI) shown in (F0). Each dot represents the mean index value of the inner cells in a single embryo.
(G) Expression of Cdx2 and Nanog in Amot-free embryos at E4.5.
(H) Expression of Cdx2 and Gata6 in Amot-free embryos at E4.5.
See Figure S3 for related data.
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1187motif interacts with Kibra (Figures S4B and S4C). Amot also
interacts with the junctional proteins MUPP1/Patj via the
C-terminal PDZ domain-binding motif [25, 26]. To examine
the importance of these motifs, we also expressed Amot-
mPY123, which had mutations in all three PY motifs, and
Amot-DPDZbd, which lacked the C-terminal PDZ domain-
binding motif, in Amot-free embryos (Figure 4A). The rescue
activities of Amot-mPY123 and Amot-DPDZbd appeared to
be weaker than that of unmodified Amot, but they clearly
rescued the mutant phenotype (Figures 4B and 4C), thereby
indicating that these motifs do not play critically important
roles by themselves.
The N-Terminal and Coiled-Coil Domains Are Both
Required for Efficient Interaction with Lats2
The N-terminal domain of Amotl2 binds to and activates Lats2
[36]. Thus, we examined the requirements of the Amot
domains for interaction with Lats2 by coimmunoprecipitation
(coIP) of tagged proteins expressed in HEK293T cells. In
HEK293T cells, endogenous Amot130, but not Amot80, coim-
munoprecipitated with exogenous Lats2 (Figure 4D). When
overexpressed, Amot80 also interacted with Lats2, but this
interaction was clearly weaker than that with Amot130 (Fig-
ure S4D). Amot-DCC did not interact with Lats2 (Figure 4E).
Therefore, the functionally important N-terminal and coiled-
coil domains are both required for the strong interaction
between Amot and Lats2.
The N-Terminal Domain Is Also Required for the
Actin-Binding Activity and the Merlin-Mediated Interaction
with the E-Cadherin Complex
Amot80 did not exhibit strong signals in AJs (Figure 4B), and
thus,weexamined themolecular basisof this result. Consistent
with a previous report that theN-terminal domainof Amot inter-
acts with and promotes the formation of F-actin [37], Amot130-
expressing HEK293T and NIH 3T3 cells formed thick F-actin
bundles where Amot130 colocalized, whereas Amot80 did not
exhibit these activities (Figures 4F and S4E). Therefore, the
localization to AJs may involve binding to cortical actin fibers.
To further elucidate the relationship between Amot and
AJs, we examined the interaction between Amot and the
E-cadherin complex. When E-cadherin was immunoprecipi-
tated from cell lysates coexpressing E-cadherin and Amot,
weak coIP of Amot was observed (Figure 4G). Amot interacts
with Merlin [28], which also interacts with a-catenin, a core
component of cadherin complexes [38]. Thus, we hypothe-
sized that the interaction between Amot and the E-cadherin
complex involved Merlin. As expected, coexpression of Merlin
enhanced coIP of Amot and E-cadherin (Figure 4G). Amot in-
teracts directly with Merlin via its coiled-coil domain [28]. In
support of the importance of its interaction with Merlin,
Amot-DCC did not interact with E-cadherin (Figure 4G). We
also observed weak coIP of Amot80 and E-cadherin, but no
enhancement was observed by the coexpression of Merlin
(Figure 4G; data not shown). Amot130 and Amot80 con-
tain the coiled-coil domain, and thus, the N-terminal domain
has accessory roles that stabilize its interaction with the
E-cadherin complex.
Amot also had weak coIP with E-cadherin-DC, which lacked
the b-catenin interaction domain [39, 40] (Figure 4H). The inter-
action of a-catenin with cadherin requires b-catenin, and thus,
this result suggested that a catenin-independent mechanism
was also involved in the interaction between Amot and E-cad-
herin. Consistent with the hypothesis that Merlin cooperateswith a-catenin, Merlin did not interact with E-cadherin-DC,
and the interaction between Amot and E-cadherin-DC was not
enhanced by Merlin (Figure 4H). Overall, these results suggest
that the N-terminal domain of Amot is essential for its strong
interaction with Lats2 for actin binding and for the strong
Merlin-dependent interaction with the E-cadherin complex.
Phosphorylation of the Lats Target Site in Amot, S176,
Activates the Hippo Pathway
The N-terminal domain of Amot-family proteins possesses a
sequence, HVRSLS, which matches the consensus motif for
the Lats phosphorylation site HxRxxS [29, 41]. The 176th serine
residue (S176) in this Amot motif is a possible Lats phosphor-
ylation site (Figure 5A). We generated an antibody that recog-
nized phosphorylated S176 specifically (p-S176). In the
western blot analysis, this antibody detected Amot, but not
the nonphosphorylatable mutant Amot-S176A (Figure 5B). In
preimplantation embryos, this antibody produced signals in
the inner cell AJs (Figure 5C). These signals were not observed
in the embryos treated with l phosphatase or Amot-free
embryos (Figure 5D), which indicated that the antibody specif-
ically detected phosphorylated Amot (p-S176-Amot).
Western blot analysis of cell lysates expressing Lats2 or ki-
nase activity-negative Lats2 (Lats2-KN) detected Lats activity-
dependent phosphorylation of S176 (Figure 5E). In embryos,
junction-localized p-S176-Amot was not detected in Lats1/2
DKD embryos but was ectopically observed in Lats2-overex-
pressing embryos (Figure 5F). These results suggest that
Lats phosphorylated S176 in Amot in the AJs of the inner cells.
p-S176-Amot localized to the AJs of the Hippo-active inner
cells, and thus, we examined the role of this phosphorylation
in the Hippo pathway activation. RNA injection into Amot-free
embryos showed that the nonphosphorylatable mutant Amot-
S176A had the very weak rescue activity of the mutant pheno-
type (Figures 5G–5I). The inner cells exhibited nuclear Yap,
and the p-Yap signal remained very low (Figure 5H). Similar to
Amot80, the level of Amot-S176A was low, and no clear signal
was observed in the AJs (Figure 5H). In contrast, a phosphomi-
metic mutant, Amot-S176E, excluded Yap from the inner cell
nuclei (Figures 5G–5I). Importantly, Yap was also excluded
from the outer cell nuclei, which suggests that Amot-S176E is
a constitutively active protein, although the degree and fre-
quency of nuclear exclusion in the outer cells were lower than
those in the inner cells (Figures 5H and 5I). Ectopic activation
of Hippo signaling was also confirmed by increased p-Yap sig-
nals (Figure 5H). The Amot-S176E proteins formed dense
discrete dots on the plasmamembranes (Figure 5H). These re-
sults suggest that the phosphorylation of S176 has critically
important roles in controlling the functions of the N-terminal
domain: localization/stabilization in the AJs and the activation
of the Hippo pathway. Therefore, the phosphorylation of S176
in Amot is important for Hippo pathway activation in AJs.
Phosphorylation of S176 Suppresses the Actin-Binding
Activity of Amot
To determine the molecular basis of Hippo pathway activation
via the phosphorylation of S176, we investigated how this
phosphorylation modifies the molecular properties of Amot.
First, we examined the actin-binding activity. In HEK293T
and NIH 3T3 cells, Amot-S176A had actin polymerization and
binding activities similar to Amot, whereas Amot-S176E had
neither activity (Figures 6A and S5A). Therefore, nonphos-
phorylated Amot binds to actin, and the phosphorylation of
S176 suppresses its actin-binding activity.
A C
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Figure 4. The N-Terminal Domain of Amot Is Required for Actin Polymerization, Association with AJs and Lats2, and Hippo Pathway Activation
(A) Schematic representations of mutant Amot proteins.
(B) Representative results from the rescue experiments. mRNAs encoding the proteins indicated were injected into wild-type or Amot-free embryos. The
upper panels show the distributions of injected Amot proteins (except the wild-type embryos). The lower panels show the distributions of Yap proteins.
(C) Graphs summarizing the rescue activities of each protein. The numbers in the graphs show the number of embryos in each category.
(D) Coimmunoprecipitation experiments showing the interaction between endogenous Amot130 and Lats2.
(legend continued on next page)
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Merlin-Dependent Interaction between Amot and the
E-Cadherin Complex
We examined the effects of S176 phosphorylation on the inter-
action between Amot and the E-cadherin complex. Amot-
S176A and Amot-S176E had Merlin-dependent interactions
with E-cadherin (Figure S5B). Therefore, the phosphorylation
status of S176 did not have significant effects on the interac-
tion between Amot and the E-cadherin complex.
Phosphorylation of S176 in Amot Is Required for Its Strong
Interaction with Lats
Finally, we examined the effects of S176 phosphorylation on
the interaction between Amot and Lats2. In coIP experiments,
Amot-S176A and Amot-S176E had weak and strong interac-
tions with Lats2, respectively (Figure 6B). Therefore, the phos-
phorylation of S176 is required for the strong interaction with
Lats2. Consistent with the idea that S176 is a Lats target site,
Amot did not have clear interaction based on coIP from the
lysates of cells cotransfected with Amot and Lats2-KN (Fig-
ure 6C). In this system, Amot-S176E had a strong interaction
with Lats2-KN (Figure 6C). These results suggest that the
phosphorylation of S176 by Lats enhances the interaction
between Amot and Lats.
Strong Correlations between Lats Binding, Protein
Stability at AJs, and Hippo Pathway Activation
Further support of the importance of S176 phosphorylation
was provided by the correlations between Lats binding, the
in vivo protein stability at AJs, andmutant rescue activity using
two additional deletion mutants of Amot. One mutant, Amot-
D(45–100), had a strong interaction with Lats2 (Figures 6D
and 6E). In rescue experiments, Amot-D(45–100) protein was
abundant, including in AJs, where S176 was phosphorylated,
and the embryos exhibited clear nuclear exclusion of Yap,
which was an indication of the strong activation of the Hippo
pathway, in all cells (Figures 6F and 6G). Amot-D(45–100) acti-
vated the Hippo pathway without disturbing the cell polarity,
which was demonstrated by apically localized PKCl/z (Fig-
ure S5C). The second mutant, Amot-D(101–141), which had
only a very weak interaction with Lats2 (Figures 6D and 6E),
was not detected in embryos and failed to rescue the mutant
phenotype (Figures 6F and 6G). Therefore, the phosphoryla-
tion of S176 by Lats is an important step during Hippo pathway
activation in AJs, which includes protein stabilization in the
AJs and a stable interaction with Lats.
Discussion
Combination of Cell Adhesion and Cell Polarity Converts
Positional Information into Cell Fate via Hippo Signaling in
Preimplantation Embryos
We previously showed that cell position-dependent Hippo
signaling is the key mechanism underlying position-depen-
dent cell fate specification in preimplantation embryos [6, 8].
In the present study, we demonstrated the involvement of(E) Coimmunoprecipitation experiments showing the requirement for the coile
(F) F-actin polymerization and actin-binding activities of Amot proteins in NIH
(G) Coimmunoprecipitation experiments showing the interactions of Amot with
was not enhanced by Amot.
(H) Coimmunoprecipitation experiments showing the requirement for the b-c
with Amot.
See Figure S4 for related data.cell polarity and cell-cell adhesion with the regulation of Hippo
signaling. In the outer cells, the presence of cell polarity or the
operation of the Par-aPKC system suppressed the activation
of the Hippo pathway via cell-cell adhesion. In the inner cells,
the absence of cell polarity facilitated Hippo pathway activa-
tion via cell-cell adhesion, thereby leading to ‘‘inside-ON,
outside-OFF’’ differential Hippo signaling in the embryo. This
mechanism implies that cells in preimplantation embryos
interpret their positional information via a combination of two
cellular processes, i.e., cell polarity and cell-cell adhesion, to
control their cell fate. Furthermore, this mechanism is consis-
tent with the two historical models of the initial cell fate spec-
ification process: the inside-outside model [1] and the newer
version of the polarity model [3, 4].
A Model of Amot-Dependent Hippo Pathway Regulation in
Preimplantation Embryos
At the molecular level, the localization of Amot-family proteins
to AJs is essential for the activation of the Hippo pathway,
while the cell polarity/Par-aPKC system controls the AJ local-
ization of Amot. The roles of Amot in Hippo pathway activation
and the establishment of position-dependent Hippo signaling
are summarized in the following model (Figure 6H).
In the inner cells, (1) Amot localizes to AJs by binding to
cortical F-actin and the E-cadherin complex by interacting
with Merlin. E-cadherin and Amot are probably connected by
a large complex of E-cadherin-b-catenin-a-catenin-Merlin-
Amot because Merlin interacts with a-catenin [38] and Amot
[28]. In support of this model, Nf2/Merlin is required for activa-
tion of the Hippo pathway in preimplantation embryos (as seen
in the work of Cockburn et al. [42] published in this issue of
Current Biology). In this state, Amot is fairly unstable and is
probably degraded via ubiquitination [35]. (2) Lats phosphory-
lates S176 in the AJ-associated Amot. The dimerization of
E-cadherin [43] may contribute to Amot phosphorylation by
promoting the dimerization and/or cross-phosphorylation of
Lats [44, 45]. (3) p-S176-Amot is detached from cortical F-actin
and is stabilized in the AJs. p-S176-Amot also forms a stable
complex with Lats, which activates the Hippo pathway, prob-
ably by activating Lats. This may not be the only mechanism,
but the phosphorylation of S176-Amot is an important molec-
ular switch that turns on the Hippo pathway in AJs.
In the outer cells, the operation of the Par-aPKC system se-
questersAmot fromthebasolateralAJs to theapicalmembrane
domain. AJs lack the essential switching protein, Amot, and
thus, AJs do not activate Lats, and the Hippo pathway remains
inactive. Nonphosphorylated Amot probably binds to apical
actin bundles. The mechanism by which cell polarity restricts
Amot remains to be elucidated. The direct/indirect interaction
of Amot with the polarity regulators Par3 and Crumbs and the
junctional proteins Patj/MUPP1 [25, 26, 46] probably contrib-
utes to the regulation of the subcellular localization of Amot.
General Roles of Amot in the Hippo Pathway
How general are the mechanisms described above? An Amot-
mediated mechanism does not operate inDrosophila becaused-coil domain of Amot for the interaction with Lats2.
3T3 cells. Exogenous Amot proteins were detected using the HA tag.
E-cadherin and Merlin. Note that interaction between Merlin and E-cadherin
atenin-binding domain of E-cadherin in the Merlin-dependent interaction
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Figure 5. Phosphorylation of S176 in Amot by Lats Activates the Hippo Pathway
(A) Identification of the Lats phosphorylation consensus sequence in the N-terminal domain of Amot-family proteins. The amino acid sequences of the
mouse proteins are shown.
(B) Western blot analysis showing the specificity of anti-p-S176-Amot antibody. The anti-p-S176-Amot and anti-Amot antibodies detected endogenous
(lower bands) and tagged-exogenous (upper bands indicated with arrowheads) Amot proteins.
(C) Localization of p-S176-Amot to AJs in the inner cells of 32-cell stage embryos.
(D) Anti-p-S176-Amot antibody specifically detected phosphorylated Amot proteins. Amot-free and phosphatase-treated embryos did not exhibit signals.
(E) Western blot analysis showing the Lats-dependent phosphorylation of S176-Amot.
(F) Distribution of p-S176-Amot in Lats1/2 DKD and Lats2-overexpressing embryos. The efficient knockdown of Lats1/2 in Lats1/2 DKD embryos was
confirmed by the nuclear accumulation of Yap in all blastomeres, which was similar to that in Lats12/2; Lats22/2 embryos (data not shown).
(G) Schematic representations of mutant Amot proteins.
(H) Distribution of Amot-S176A/E, Yap, and p-Yap proteins in an Amot-free embryo. The arrowheads indicate outer cells that exhibited the clear nuclear
exclusion of Yap.
(I) Graphs summarizing the rescue activities of each protein. The numbers in the graphs show the number of embryos in each category.
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to differ in epithelial cells and preimplantation embryos. Amot
is localized to the tight junctions of polarized epithelial cells
and outer cells. However, the outer cells exhibit nuclear Yap,
while the epithelial cells suppress nuclear Yap by activating
the Hippo pathway and tethering Yap to tight junctions [23,
27, 36]. Despite these differences, Amot activates the Hippo
pathway via Lats at intercellular junctions in the inner andepithelial cells [36]. The relationship between the cell polarity
and Hippo pathway activation is opposite in these cell types,
but there must be common activation mechanisms, which
probably involve the phosphorylation of S176.
An important feature of Amot is its actin-binding activity, and
we determined correlations between S176 phosphorylation,
actin binding, Lats binding, and Hippo pathway activation.
F-actin suppresses Hippo signaling via Lats in cultured cells
A B
C
D
E
F
G
H
Figure 6. Phosphorylation of S176 in Amot Stabilizes the Interaction with Lats2
(A) F-actin polymerization and actin-binding activities of Amot-S176A/E proteins in NIH 3T3 cells. Exogenous Amot proteins were detected with the HA tag.
(B) Coimmunoprecipitation experiments showing the interaction of Amot-S176A/E with Lats2.
(C) Coimmunoprecipitation experiments showing the interaction of Amot-S176A/E with Lats2-KN.
(D) Schematic representations of the mutant Amot proteins.
(E) Coimmunoprecipitation experiments showing the interaction between Amot-D(45–100)/D(101–141) and Lats2.
(F) Distribution of Amot, p-S176-Amot, and Yap proteins in Amot-D(45–100)/D(101–141)-expressing Amot-free embryos. The arrowheads indicate outer cells
that exhibited clear nuclear exclusion of Yap.
(G) Graphs summarizing the rescue activities of each protein. The numbers in the graphs show the number of embryos in each category.
(H) Model of Amot-regulated differential Hippo activation in preimplantation embryos.
a, a-catenin; b, b-catenin; Mer, Merlin; AJ, adherens junction. See Discussion for details. See Figure S5 for related data.
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1192[47, 48], and thus, it is intriguing to speculate that Amot is
involvedwith the actin-mediated regulation of Hippo signaling.
It is also likely that Hippo signaling controls F-actin by modu-
lating the actin-binding/polymerization activity of Amot via
phosphorylation. In this context, it is interesting to note that
the apical domain of the outer cells of the preimplantation
embryo, in which the Hippo pathway is inactive, contained a
large amount of cortical F-actin.
Roles of Hippo Signaling during Cell Fate Specification in
Preimplantation Embryos
In the context of preimplantation embryos, two important
questions need to be addressed in future. Cell polarization is
the first important step during the establishment of position-
dependent Hippo signaling. Therefore, the first question is,
what promotes the initial polarization of the outer cells, either
in the early embryo or in isolated ICMs [49]? The second ques-
tion is, what is the relationship between the Hippo-regulated
mechanism and other mechanisms during initial cell fate
specification? Several different mechanisms are known to
operate, including very early biases among blastomeres and
polarity-dependent asymmetric segregation of mRNAs (see
the reviews and references in [50, 51]). Irrespective of the oper-
ation of these mechanisms, the experimental manipulation of
16-cell and 32-cell stage embryos demonstrated the complete
and partial adjustment of cell fates, respectively, with new cell
positions [32]. Therefore, the continuous operation of position-
dependent Hippo signaling after the 16-cell stage probably
has central roles in cell fate specification by generating,
enhancing, and stabilizing position-dependent differences
throughout preimplantation development. However, it is
important to clarify the relationship among these different
mechanisms during normal developmental processes.
Experimental Procedures
Housing of Mice
Mice were housed in environmentally controlled rooms in the Laboratory
Animal Housing Facility at the RIKEN Center for Developmental Biology
(CDB) and the Center for Animal Resources and Development (CARD) at
Kumamoto University. All experiments were performed according to the
regulations for animal and recombinant DNA experiments at RIKEN CDB
and Kumamoto University and the laws and notifications of the Japanese
government. All experiments were also approved by the institutional com-
mittees for animal and recombinant DNA experiments at RIKEN CDB and
Kumamoto University.
Mouse Lines
Wild-type embryos were obtained by intercrossing (C57BL/6xDBA)F1
(BDF1) or by crossing ICR female with BDF1 male mice. The Amot
mutant (CDB accession no. CDB0089K; http://www.cdb.riken.jp/arg/
mutant%20mice%20list.html) [34] and PKCl mutant [31] mice were
described previously. PKCz mutant mice were generated via homologous
recombination in ES cells. Detailed procedures for the production of PKCz
mutant mice and genotype determination are provided in the Supplemental
Experimental Procedures.
DNA/RNA Injection into Preimplantation Embryos
Poly(A)-tailed RNA was injected into both blastomeres of two-cell stage
embryos, as described previously [6]. An RNA concentration of 25 ng/ml
was used in the rescue experiments. To achieve gene knockdown by the
injection of siRNAs, we injected Stealth RNAi siRNAs (Invitrogen) into both
blastomeres of two-cell stage embryos at a concentration of 8 mM. The
purified and verified shRNA plasmid DNA solution (10 ng/ml) was injected
into the male pronuclei using standard protocols [13, 52]. The embryos
were cultured for 48 hr and 80 hr after injection to analyze 32-cell and
late blastocyst stage embryos, respectively. Details of the plasmids and
siRNAs used as well as other embryo manipulations are provided in the
Supplemental Experimental Procedures.Immunofluorescent Staining and Data Acquisition
Immunofluorescent staining of preimplantation embryos and transfected
cells was performed as described previously [6, 53] with slight modifica-
tions. Goat anti-mouse, anti-rabbit, and anti-rat IgG antibodies labeled
with Alexa Fluor 488, Alexa Fluor 555 (Invitrogen), or DyLight 649 (Jackson
ImmunoResearch) were used as the secondary antibodies. Hoechst
33258 stain (DojindoMolecular Technologies) was used for nuclear staining.
Images were acquired using confocal laser scanning microscopes
LSM510META (Zeiss) or A1 (Nikon). Details of the analyses of the acquired
images are provided in the Supplemental Experimental Procedures.
Immunoprecipitation
Immunoprecipitation (IP) was performed according to previously described
procedures [54], with slight modifications. In brief, expression plasmids
(0.8 mg) were transfected into 6 3 105 HEK293T cells plated onto six-well
plates. One day after transfection, the cells were lysed with 0.5 ml of high
salt RIPA buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 1% NP-40, 0.5%
deoxycholic acid, and 0.1%SDS) supplemented with complete protease in-
hibitor cocktail (Roche). Genomic DNA was disrupted by sonication. The
lysate was centrifuged at 12,000 3 g for 10 min, and the supernatant was
diluted with 0.5 ml of NaCl-free RIPA buffer. The resulting diluted lysates
were used as samples for IP. In all of the IP experiments, FLAG-tagged pro-
teins were precipitated using anti-FLAG M2-agarose (Sigma). All the proce-
dures were performed at 4C or on ice.
Statistical Analysis
All statistical analyses were performed using Prism5 (GraphPad). Student’s
t test was used for comparisons between two groups.
Supplemental Information
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2013.05.014.
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